The Nencki Institute of Experimental Biology of the Polish Academy of Sciences is currently recruiting PhD students to the International PhD Program in Biological Bases of Human Diseases (Bio4Med).
Application deadline: September 2, 2016
Candidates for Bio4Med International PhD Program must not have resided or carried out their main activity (work, studies, etc.) in Poland for more than 12 months in the past 3 years.
The major aim of Bio4Med (Biology for Medicine) programme is to provide unique, international, inter-disciplinary and intersectoral doctoral training for Early Stage Researchers (ESRs) in the domain of biological bases of human diseases. To achieve this goal it combines 22 leading research groups at the Nencki Institute and their scientific partners from world-class laboratories located in EU Member States, Switzerland, Ukraine, Japan, Canada and US.
Research programme includes basic science PhD-projects focused on molecular basis of neurodegeneration, neurological disorders, cancer and metabolic diseases. All supervising researchers engaged in the Bio4Med are at the international forefront of biomedical research and have experience in PhD student supervision.
Bio4Med programme will foster young researchers’ career development and employability by addressing the following objectives:
- to offer excellent training in modern biology and endow ESRs with unique scientific knowledge, and experience in cutting-edge experimental techniques;
- to enhance research-oriented and transferable skills of ESRs;
- to promote scientific mobility via international, inter-disciplinary and inter-sectoral collaboration.
The objectives of Bio4Med will be delivered through activities encompassing practical laboratory training, hands-on workshops, lectures corresponding to the theoretical aspects of doctoral projects, research-oriented generic skills courses, transferrable skills courses, progress talks and meetings. The training programme itself, focused on medically important issues, will make ESRs highly attractive to commercial enterprises, particularly in biotechnology and pharmaceutical sectors.